NCT Number: NCT00145756
China Salt Substitute Study
Cardiovascular disease is a leading cause of death and disability worldwide, and blood pressure is a leading determinant of this risk. To date, strategies for blood pressure lowering have focused on drug treatment but dietary interventions such as reducing sodium intake and increasing potassium intake may also be effective. Such interventions may be particularly suitable for low- and middle-income countries in which significant dietary changes may be more easily achieved. This study will test the effect of a salt substitute on blood pressure, among individuals at high-risk from cardiovascular disease in Northern China.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
The Institute for Medical Science of Mudangjiang, Mudanjiang, Heilongjiang, China
About this study
This randomised trial will clearly identify whether a low-sodium, high-potassium salt-substitute is a feasible means of lowering blood pressure in high-risk individuals in rural China. The randomised design and the large size (n=600) will ensure that the results are reliable and precise. The 12-month duration will address the long-term practicability of the intervention strategy. The study is being conducted because salt-substitute-based blood pressure lowering may be particularly appropriate for rural populations in low- and middle-income countries. First, sodium intake is often very high. Second, the salt-substitute can be easily incorporated into the diet because most food is prepared and eaten at home. Third, the intervention can be provided at very low cost.
Comparisions: Low sodium high potassium salt (65% sodium chloride, 25% potassium chloride, 10% magnesium sulphate) compared to normal salt (100% sodium chloride).
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participant inclusion will be based upon the presence of:
- A doctor-confirmed high risk of future vascular disease defined as a history of any one of:
- Stroke or transient ischaemic attack
- Hospitalisation for management of any acute coronary syndrome
- Surgery or angioplasty for peripheral vascular disease
- Treated diabetes and age 55 years or older
- Systolic blood pressure >160mmHg
- Estimated daily sodium intake of 260mmol/24hrs (about 15g/24hrs of NaCl) or above and expectation that at least 50% of daily dietary salt intake can be replaced with the salt-substitute. This will be estimated through interview of the potential participant and the individual responsible for daily food preparation (if this is not the patient) using a structured questionnaire.
- Provision of informed consent
Exclusion criteria
Potential participants will be excluded if:
- they are on potassium-sparing medication
- there is an established history of significant renal impairment that would preclude the use of the salt-substitute in the opinion of the responsible physician.
- there is any reason why either the salt-substitute or normal salt are definitely indicated or definitely contra-indicated.
Treatment and study plan
Primary outcomes
-
Clinical blood pressure
Secondary outcomes
-
Spot urine sodium and potassium levels
-
Food taste
-
Preferred level of saltiness
Sponsors and collaborators
Lead sponsor
The George Institute
Other
Collaborators
- Fu Wai Cardiovascular Institute and Hospital
- James Cook University, Queensland, Australia
- University of Auckland, New Zealand
Registry information
Official study title
China Salt Substitute Study-A Randomised Trial to Determine the Long-Term Effects of a Low Sodium, High Potassium Salt Substitute on Blood Pressure Among High-Risk Individuals in Northern China
Important dates
- Study start
- 2004
- Study completion
- 2005
- First posted
- Sep 5, 2005
- Registry last updated
- Sep 5, 2005
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System
NCT02439775
Cardiovascular Diseases, Hypertension
Huntsville, Alabama, United States
View Trial DetailsImproving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination
NCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsMilitary Health and Nutrition Examination Study
NCT06380322
Cardiovascular Diseases, Diabetes Mellitus
Fort Carson, Colorado, United States
View Trial DetailsRemote Vinyasa Yoga Program for Heart Health
NCT06961981
Cardiovascular Diseases, Hypertension
Morgantown, West Virginia, United States
View Trial Details